The prevalence of GERD with weekly symptoms is 10%-20% in Europe and North America.
Survival is worse among men living in these hot spots.
Findings could help prioritize surgical procedures amidst the COVID-19 pandemic.
Findings from the phase 2 InterAACT trial.
The approval was based on the KEYNOTE-177 trial.
Trial included patients with HER2+ LA/mGC in the phase 1 component.
Information could shed light on risks and benefits of colonoscopy in older patients.
Antibiotics increase the risk for colon, but not rectal cancer by altering the gut microbiota composition.
A predictive role for IL-27 was demonstrated in 2 large prospective cohort studies.
The treatment will be available under the Cancer Drugs Fund
Many advanced gastric cancers are resistant or unresponsive to anti-PD-1 therapies.
The latest recommendations update those published in January 2020.
Prediction of life expectancy in patients with hepatocellular carcinoma and spinal metastases.
Treatment options are limited for advanced-stage ESCC.
The treatment will be available through the EAMS for unresectable hepatocellular carcinoma that has not previously been treated with systemic therapy
The Viability Testing and Transplantation of Marginal Livers trial.
Several programmes were paused in March due to the COVID-19 pandemic.
